Nasdaq
NBIX
Neurocrine Biosciences, Inc.
- Health Care
- Listed 1996
- 1 day
- −1.0%
- 1 month
- −10.0%
- 1 year
- +24.4%
$159.82 · Mkt cap $16.2B · P/E 34.22
At the 6 Aug 2026 close
Nasdaq
Neurocrine Biosciences, Inc.
$159.82 · Mkt cap $16.2B · P/E 34.22
At the 6 Aug 2026 close
Neurocrine Biosciences, Inc. trades under the ticker NBIX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 1996. Its market capitalisation is $16.2B. The last closing price was $159.82, on 6 Aug 2026. It trades at 34.22 times its last reported annual diluted earnings per share. Over the past year the share price is +24.4%, and −10.0% over the past month. Returns are price returns and exclude dividends.
This page exists because NBIX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.